Medifast, Inc. Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Medifast (MED) Tops Q1 EPS by 3c, Offers Guidance
May 2, 2022 4:21 PM EDTMedifast (NYSE: MED) reported Q1 EPS of $3.59, $0.03 better than the analyst estimate of $3.56. Revenue for the quarter came in at $417.6 million versus the consensus estimate of $402.42 million.
GUIDANCE:
Medifast sees FY2022 EPS of $14.60-$16.05, versus the consensus of $15.62. Medifast sees... More
